Your browser doesn't support javascript.
loading
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.
Fujimoto, Airi; Koutake, Yoshimichi; Hisamatsu, Daisuke; Ookubo, Noriko; Yabuuchi, Yurika; Kamimura, Go; Kai, Tatsuo; Kozono, Aki; Ootsu, Takahiro; Suzuki, Hiroto; Matsuo, Keisuke; Kuwahara, Kimiko; Oiwane, Yoshita; Nagata, Yuko; Tanimoto, Kenya; Sato, Eri; Suenaga, Mei; Uehara, Tomohiro; Ikari, Akira; Endo, Satoshi; Hiraki, Yoichi; Kawamata, Yosei.
Afiliación
  • Fujimoto A; Department of Pharmacy, National Hospital Organization Beppu Medical Center, 473 Uchikamado, Beppu, Oita, 874-0011, Japan. fujimoto.airi.kc@mail.hosp.go.jp.
  • Koutake Y; Department of Pharmacy, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan. fujimoto.airi.kc@mail.hosp.go.jp.
  • Hisamatsu D; Department of Pharmacy, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Ookubo N; Department of Pharmacy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Yabuuchi Y; Department of Pharmacy, National Hospital Organization Miyakonojo Medical Center, Miyazaki, Japan.
  • Kamimura G; Department of Pharmacy, National Hospital Organization Fukuokahigashi Medical Center, Fukuoka, Japan.
  • Kai T; Department of Pharmacy, National Hospital Organization Minamikyusyu Hospital, Kagoshima, Japan.
  • Kozono A; Department of Pharmacy, National Hospital Organization Miyazaki Higashi Hospital, Miyazaki, Japan.
  • Ootsu T; Department of Pharmacy, National Hospital Organization Kumamoto Saishun Medical Center, Kumamoto, Japan.
  • Suzuki H; Department of Pharmacy, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
  • Matsuo K; Department of Pharmacy, National Hospital Organization Okinawa National Hospital, Okinawa, Japan.
  • Kuwahara K; Department of Pharmacy, National Hospital Organization Beppu Medical Center, 473 Uchikamado, Beppu, Oita, 874-0011, Japan.
  • Oiwane Y; Department of Pharmacy, National Hospital Organization Ureshino Medical Center, Saga, Japan.
  • Nagata Y; Department of Pharmacy, National Hospital Organization Omuta National Hospital, Fukuoka, Japan.
  • Tanimoto K; Department of Pharmacy, National Hospital Organization Fukuoka National Hospital, Fukuoka, Japan.
  • Sato E; Department of Pharmacy, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
  • Suenaga M; Department of Pharmacy, National Hospital Organization Miyakonojo Medical Center, Miyazaki, Japan.
  • Uehara T; Department of Pharmacy, National Hospital Organization Kumamoto Saishun Medical Center, Kumamoto, Japan.
  • Ikari A; Department of Pharmacy, National Hospital Organization Okinawa National Hospital, Okinawa, Japan.
  • Endo S; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, Japan.
  • Hiraki Y; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, Japan.
  • Kawamata Y; Department of Pharmacy, National Hospital Organization Beppu Medical Center, 473 Uchikamado, Beppu, Oita, 874-0011, Japan.
Cancer Immunol Immunother ; 72(7): 2169-2178, 2023 Jul.
Article en En | MEDLINE | ID: mdl-36849845

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Japón